Equities

Welcia Holdings Co Ltd

Welcia Holdings Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)1,877.50
  • Today's Change17.00 / 0.91%
  • Shares traded386.90k
  • 1 Year change-25.48%
  • Beta0.1240
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Welcia Holdings Co Ltd is a Japan-based company mainly engaged in the retail business focusing on pharmaceuticals, preparations, cosmetics. The Company is engaged in the provision of the retail business based on a drug store. The Company is mainly engaged in the sale of pharmaceuticals, hygiene care products, baby products, health foods, preparations, cosmetics, household miscellaneous goods and foods.

  • Revenue in JPY (TTM)1.24tn
  • Net income in JPY21.93bn
  • Incorporated2008
  • Employees15.29k
  • Location
    Welcia Holdings Co Ltd2-2-15, Soto KandaCHIYODA-KU 101-0021JapanJPN
  • Phone+81 352075878
  • Fax+81 352075880
  • Websitehttps://www.welcia.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
3141:TYO since
announced
Transaction
value
TEPCO PARTNERS Co IncAnnounced05 Jul 202405 Jul 2024Announced-4.89%--
WelparkAnnounced18 Apr 202418 Apr 2024Announced-18.58%22.28m
Xchange IncAnnounced17 Jan 202417 Jan 2024Announced-21.01%--
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sipai Health Technology Co, Ltd98.92bn-5.15bn84.89bn3.25k--2.66--0.8582-0.3305-0.33056.552.111.5813.619.781,609,185.00-7.98---13.82--9.18---5.05--1.58--0.0386--14.39--81.34------
JZJ Chain Drugstore Corp198.92bn5.06bn92.92bn16.65k18.131.57--0.46711.531.5360.2017.720.92582.2020.72559,572.202.345.754.5011.1735.5435.212.535.040.26552.880.656336.6220.8426.8410.7225.4123.62--
Genky DrugStores Co Ltd188.04bn6.46bn96.39bn1.66k14.641.977.920.5126212.46212.466,180.371,582.201.676.4743.31113,208,300.005.764.948.657.8620.4120.673.442.980.410259.820.41958.249.3512.2132.7518.58-0.53160.3968
Fangzhou Inc52.60bn-18.38bn150.36bn515.00------2.86-0.6906-0.69061.98-1.59------5,143,855.00--------20.52---34.94--0.699--30.75--10.43--48.66------
MedPlus Health Services Ltd109.67bn1.83bn160.72bn21.00k87.915.3725.861.478.378.37500.31136.891.973.55447.432,855,699.003.292.684.023.4822.6621.141.671.380.65981.770.38630.0023.4219.8731.5740.5931.14--
Welcia Holdings Co Ltd1.24tn21.93bn390.17bn15.29k17.541.568.480.3154106.05106.055,982.481,194.412.116.3117.0880,917,640.003.675.766.6310.2330.2330.811.742.510.651138.940.234323.976.389.33-2.148.712.5910.12
Dashenlin Pharmaceutical Group Co Ltd566.67bn18.15bn391.01bn45.47k21.602.67--0.690.74450.744523.376.031.124.1423.28583,716.303.906.578.1512.6333.8037.513.475.540.5987.150.598145.6715.4522.5912.6317.0226.516.85
Yifeng Pharmacy Chain Co Ltd510.72bn32.53bn609.66bn39.65k18.712.78--1.191.261.2619.778.460.97344.0014.51603,225.006.726.9312.7612.4738.4738.736.906.710.877134.970.523726.5613.5926.7211.5727.6625.9333.54
MatsukiyoCocokara & Co1.04tn51.47bn840.91bn13.37k16.331.6311.220.8082123.90123.902,504.461,240.241.474.8218.1277,817,220.007.306.809.568.8734.8533.454.984.571.21--0.037428.657.4912.1629.1115.9029.3811.10
Alibaba Hlth Infrmtn Tchnlgy Ltd604.56bn25.73bn1.20tn1.42k45.063.6944.641.990.08340.08341.981.021.3612.9639.0921,217,590.005.791.897.622.5423.1521.674.261.492.11--0.00440.000.984739.6164.93--30.14--
JD Health International Inc1.17tn55.83bn1.81tn3.18k32.121.6329.931.550.89040.890418.6117.560.85197.84157.4018,866,800.004.07-8.615.16-10.7022.5722.764.78-10.393.35--0.0042--14.5445.64463.4958.3895.69--
Data as of Nov 22 2024. Currency figures normalised to Welcia Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

10.84%Per cent of shares held by top holders
HolderShares% Held
Asset Management One Co., Ltd.as of 15 Apr 20244.32m2.06%
Nomura Asset Management Co., Ltd.as of 07 Nov 20243.69m1.76%
The Vanguard Group, Inc.as of 30 Sep 20243.49m1.66%
T. Rowe Price Associates, Inc. (IM)as of 30 Sep 20242.15m1.03%
Norges Bank Investment Managementas of 30 Jun 20241.72m0.82%
Nikko Asset Management Co., Ltd.as of 08 Nov 20241.69m0.81%
Daiwa Asset Management Co. Ltd.as of 31 Oct 20241.65m0.79%
Sawakami Asset Management, Inc.as of 30 Aug 20241.40m0.67%
Select Equity Group LPas of 29 Feb 20241.40m0.67%
BlackRock Fund Advisorsas of 07 Nov 20241.22m0.58%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.